欧盟致畸安全信号的时序特征及荷兰医疗专业人员信息传播
多数信号源于科学文献,监管行动时药品已上市中位23.9年。独立于监管沟通,科学文献和致畸信息服务机构可能更早向荷兰医疗专业人员传递信息。
要点
- 致畸安全信号多源于科学文献,常于上市数十年后出现。
- 监管行动时药品上市中位23.9年,范围3.2至59.3年。
- 科学文献和致畸信息服务机构可能早于监管决策提供信息。
核心结论
- 致畸安全信号主要由科学文献驱动,常在上市数十年后出现。
- 科学出版物和致畸信息服务机构可提供早期指导,常先于监管决策。
研究设计与样本
- 记录每个信号的上市许可、首次自发报告、科学发表、监管决定及通过致畸信息服务和荷兰专业期刊传播的日期。
主要发现
- 监管行动时药品上市中位时间23.9年(范围3.2-59.3年)。
- 所有信号均修订产品信息,8个(33%)还触发了直接医疗专业人员沟通。
关键数值与推荐
- 监管行动包括产品信息修订(全部信号)和直接医疗专业人员沟通(8个,33%)。
- 信号来源:科学文献18个(75%),其余来源未具体报告。
临床怎么用
- 临床药学医生应关注科学文献和致畸信息服务机构的信息,可能早于监管沟通。
- 对上市多年的药品仍需警惕致畸信号,尤其基于文献报道时。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Although regulatory responses to safety signals have been studied, pregnancy-specific data and their dissemination to medical professionals remain unclear. This study examined the characteristics and temporal trends of teratological safety signals prompting the European Medicines Agency to implement risk minimization measures. A secondary aim was to investigate how information on these signals, independent of regulatory communication, was disseminated to medical professionals in the Netherlands. METHODS: Teratological safety signals from 2002 to 2022 were retrieved from the European Pharmacovigilance Issues Tracking Tool. For each signal, we recorded the dates of market authorization, first spontaneous report, scientific publication, regulatory decision and dissemination through the Teratology Information Service (TIS) and Dutch professional journals. The source of the signal (spontaneous reports, scientific literature or otherwise) was assessed. Time intervals between events were calculated and visualized. RESULTS: Twenty-four safety signals pertaining to fetal teratogenesis were identified. At the time of regulatory action, medicines had been on the market for a median of 23.9 years (range 3.2-59.3). Cases or studies published in the scientific literature were the origin for most (n = 18, 75%) teratological safety signals. Amendments of the product information was a regulatory action for all signals; eight (33%) also triggered Direct Healthcare Professional Communications. Apart from these regulatory communications, information may have reached healthcare professionals through scientific literature or other channels, sometimes before and sometimes alongside regulatory decisions. CONCLUSION: Teratological safety signals are predominantly scientific literature-driven and often arise decades after marketing. Scientific publications and TIS may provide early guidance, frequently preceding regulatory decisions.
引用
- van Rijt-Weetink YRJ, Huisman RE, van Wieringen JP, et al. Characteristics and temporal trends of EU teratological safety signals and information dissemination to healthcare professionals in the Netherlands-A contribution of the ConcePTION project. Br J Clin Pharmacol. 2026. PMID: 42210341. doi:10.1002/bcp.70615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。